1 October 2023 false No description of principal activity Taxfiler 2024.6 09787196business:PrivateLimitedCompanyLtd2023-10-012024-09-30 097871962023-09-30 097871962023-10-012024-09-30 09787196business:AuditExempt-NoAccountantsReport2023-10-012024-09-30 09787196business:FilletedAccounts2023-10-012024-09-30 097871962024-09-30 09787196business:Director12023-10-012024-09-30 09787196business:RegisteredOffice2023-10-012024-09-30 097871962023-09-30 09787196core:WithinOneYear2024-09-30 09787196core:WithinOneYear2023-09-30 09787196core:ShareCapitalcore:PreviouslyStatedAmount2024-09-30 09787196core:ShareCapitalcore:PreviouslyStatedAmount2023-09-30 09787196core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-09-30 09787196core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-09-30 09787196core:PreviouslyStatedAmount2024-09-30 09787196core:PreviouslyStatedAmount2023-09-30 09787196business:SmallEntities2023-10-012024-09-30 09787196countries:EnglandWales2023-10-012024-09-30 09787196core:MotorVehicles2023-10-012024-09-30 09787196core:MotorVehicles2023-09-30 09787196core:MotorVehicles2024-09-30 097871962022-10-012023-09-30 iso4217:GBP xbrli:pure
Company Registration No. 09787196 (England and Wales)
MRCD Pharma Services Limited Unaudited accounts for the year ended 30 September 2024
MRCD Pharma Services Limited Unaudited accounts Contents
Page
- 2 -
MRCD Pharma Services Limited Company Information for the year ended 30 September 2024
Director
G Rychlik
Company Number
09787196 (England and Wales)
Registered Office
4 Malthouse Way Worthing West Sussex BN13 3 GD
Accountants
G Schulz & Company Ltd Chartered Management Accountants G W Schulz FCMA CGMA 3 Lane Close Horsham, West Sussex RH12 3UF
- 3 -
MRCD Pharma Services Limited Statement of financial position as at 30 September 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Tangible assets
17,636 
26,454 
Investments
10 
10 
17,646 
26,464 
Current assets
Debtors
4,250 
1,794 
Cash at bank and in hand
578 
363 
4,828 
2,157 
Creditors: amounts falling due within one year
(29,534)
(12,450)
Net current liabilities
(24,706)
(10,293)
Net (liabilities)/assets
(7,060)
16,171 
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
(7,160)
16,071 
Shareholders' funds
(7,060)
16,171 
For the year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 23 June 2025 and were signed on its behalf by
G Rychlik Director Company Registration No. 09787196
- 4 -
MRCD Pharma Services Limited Notes to the Accounts for the year ended 30 September 2024
1
Statutory information
MRCD Pharma Services Limited is a private company, limited by shares, registered in England and Wales, registration number 09787196. The registered office is 4 Malthouse Way, Worthing, West Sussex, BN13 3 GD.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Motor vehicles
20% on cost
4
Tangible fixed assets
Motor vehicles 
£ 
Cost or valuation
At cost 
At 1 October 2023
44,090 
At 30 September 2024
44,090 
Depreciation
At 1 October 2023
17,636 
Charge for the year
8,818 
At 30 September 2024
26,454 
Net book value
At 30 September 2024
17,636 
At 30 September 2023
26,454 
- 5 -
MRCD Pharma Services Limited Notes to the Accounts for the year ended 30 September 2024
5
Investments
Subsidiary undertakings 
£ 
Valuation at 1 October 2023
10 
Valuation at 30 September 2024
10 
6
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
Trade debtors
4,250 
1,794 
7
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
VAT
(163)
(236)
Amounts owed to group undertakings and other participating interests
11,107 
11,257 
Taxes and social security
100 
682 
Other creditors
3,817 
273 
Loans from directors
13,765 
74 
Accruals
908 
400 
29,534 
12,450 
8
Average number of employees
During the year the average number of employees was 3 (2023: 3).
- 6 -